Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma

Clinical and Experimental Metastasis

Volumn 25, Issue 4, 2008, Pages 465-476

  Liao, Qiulin ^a   Zhao, Liang ^a   Chen, Xiaodong ^b   Deng, Yongjian ^a   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Carcinogenesis; Lymph node metastasis; Nasopharyngeal carcinoma; Serum proteome

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; PROTEOME; SERUM AMYLOID A; TUMOR ANTIGEN;

ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; DNA FINGERPRINTING; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ADULT; BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROTEOME; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 44449135877     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-008-9152-8     Document Type: Article

References (65)

1. Kumar S, Mahanta J (1998) Aetiology of nasopharyngeal carcinoma. A review. Indian J Cancer 35(2):47-56
2. Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12(6):421-429
3. Yang HY, Xiao ZQ, Li F (2004) Establishment of 2-dE map of human low differentiation nasopharyngeal carcinoma cell line CNE-2 proteome. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29(2):123-128
4. Jiang P, Gan M, Huang H et al (2005) Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells. J Proteome Res 4(2):599-605
5. Li F, Xiao Z, Zhang P et al (2007) A reference map of human nasopharyngeal squamous carcinoma proteome. Int J Oncol 30(5):1077-1088
6. Tan C, Li J, Wang J et al (2002) Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics 2(3):306-312
7. Sun Y, Yi H, Zhang PF et al (2007) Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett 581(1):131-139
8. Sun D, Zhang Z, Van do N et al (2007) Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol 43(1):82-87
9. Doustjalali SR, Yusof R, Govindasamy GK et al (2006) Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 53(1-2):20-28
10. Weinkauf M, Hiddemann W, Dreyling M (2006) Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background. Electrophoresis 27(22):4555-4558
11. Ramagli LS (1999) Quantifying protein in 2-D PAGE solubilization buffers. Methods Mol Biol 112:99-103
12. Yan JX, Wait R, Berkelman T et al (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21(17):3666-3672
13. Jackson AM, Alexandrov AB, Gribben SC et al (1993) Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer 55(6):921-925
14. Santarosa M, Favaro D, Quaia M et al (1995) Expression and release of intercellular adhesion molecule-1 in renal-cancer patients. Int J Cancer 62(3):271-275
15. Bausserman LL, Herbert PN, Rodger R et al (1984) Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim Biophys Acta 792(2):186-191
16. Raynes JG, Eagling S, McAdam KP (1991) Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 83(3):488-491
17. Hunt SM, Thomas MR, Sebastian LT et al (2005) Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J Proteome Res 4(3):809-819
18. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1(11):845-867
19. Etzioni R, Urban N, Ramsey S et al (2003) The case for early detection. Nat Rev Cancer 3(4):243-252
20. Zhang H, Liu AY, Loriaux P et al (2007) Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics 6(1):64-71
21. Anderson NL, Polanski M, Pieper R et al (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3(4):311-326
22. Thadikkaran L, Siegenthaler MA, Crettaz D et al (2005) Recent advances in blood-related proteomics. Proteomics 5(12):3019-3034
23. Nedelkov D, Kiernan UA, Niederkofler EE et al (2005) Investigating diversity in human plasma proteins. Proc Natl Acad Sci USA 102(31):10852-10857
24. Cho WC, Yip TT, Yip C et al (2004) Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 10(1 Pt 1):43-52
25. Diamandis EP (2003) Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49(8):1272-1275
26. Diamandis EP (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96(5):353-356
27. Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 3(4):367-378
28. Putnam RW (1975) The plasma proteins. New York Academic Press
29. Curry S (2002) Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang 83(Suppl 1):315-319
30. Dea MK, Hamilton-Wessler M, Ader M et al (2002) Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake. Diabetes 51(3):762-769
31. Schussler GC (2000) The thyroxine-binding proteins. Thyroid 10(2):141-149
32. Quero C, Colome N, Prieto MR et al (2004) Determination of protein markers in human serum: analysis of protein expression in toxic oil syndrome studies. Proteomics 4(2):303-315
33. Feng JT, Liu YK, Song HY et al (2005) Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5(17):4581-4588
34. Rothlein R, Mainolfi EA, Czajkowski M et al (1991) A form of circulating ICAM-1 in human serum. J Immunol 147(11):3788-3793
35. Budnik A, Grewe M, Gyufko K et al (1996) Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol 24(2):352-359
36. Harning R, Mainolfi E, Bystryn JC et al (1991) Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 51(18):5003-5005
37. Grothey A, Heistermann P, Philippou S et al (1998) Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 77(5):801-807
38. Zhang GJ, Adachi I (1999) Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. Int J Oncol 14(1):71-77
39. Nakata B, Hori T, Sunami T et al (2006) Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res 6(3):1175-1179
40. Shimizu Y, Minemura M, Tsukishiro T et al (1995) Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 22(2):525-531
41. Kitagawa T, Matsumoto K, Iriyama K (1998) Serum cell adhesion molecules in patients with colorectal cancer. Surg Today 28(3):262-267
42. Yoo NC, Chung HC, Chung HC et al (1998) Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression. Yonsei Med J 39(1):27-36
43. Becker JC, Termeer C, Schmidt RE et al (1993) Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol 151(12):7224-7232
44. d'Eril GM, Anesi A, Maggiore M et al (2001) Biological variation of serum amyloid A in healthy subjects. Clin Chem 47(8):1498-1499
45. Kimura M, Tomita Y, Imai T et al (2001) Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma. Cancer 92(8):2072-2075
46. Glojnaric I, Casl MT, Simic D et al (2001) Serum amyloid A protein (SAA) in colorectal carcinoma. Clin Chem Lab Med 39(2):129-133
47. Biran H, Friedman N, Neumann L et al (1986) Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 39(7):794-797
48. Benson MD, Cohen AS (1979) Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum 22(1):36-42
49. Diamandis EP (2004) Identification of serum amyloid a protein as a potentially useful biomarker for nasopharyngeal carcinoma. Clin Cancer Res 10(15):5293; author reply-4
50. Urieli-Shoval S, Cohen P, Eisenberg S et al (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem 46(12):1377-1384
51. Lindquist S (1986) The heat-shock response. Annu Rev Biochem 55:1151-1191
52. Subjeck JR, Shyy TT (1986) Stress protein systems of mammalian cells. Am J Physiol 250(1 Pt 1):C1-C17
53. Barnes JA, Dix DJ, Collins BW et al (2001) Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 6(4):316-325
54. Ravagnan L, Gurbuxani S, Susin SA et al (2001) Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 3(9):839-843
55. Clark PR, Menoret A (2001) The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones 6(2):121-125
56. Milicevic ZT, Petkovic MZ, Drndarevic NC et al (2007) Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma- immunohistochemistry and Western blot analysis. Neoplasma 54(1):37-45
57. Lazaris A, Chatzigianni EB, Panoussopoulos D et al (1997) Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 43(1):43-51
58. Torronteguy C, Frasson A, Zerwes F et al (2006) Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors. Cell Stress Chaperones 11(1):34-43
59. Abe M, Manola JB, Oh WK et al (2004) Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer. Clin Prostate Cancer 3(1):49-53
60. Chuma M, Sakamoto M, Yamazaki K et al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37(1):198-207
61. Lazaris AC, Theodoropoulos GE, Aroni K et al (1995) Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma. Virchows Arch 426(5):461-467
62. Kaur J, Das SN, Srivastava A et al (1998) Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features. Oral Oncol 34(2):93-98
63. Volm M, Koomagi R, Mattern J et al (2002) Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metastasis 19(5):385-390
64. Mambula SS, Calderwood SK (2006) Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia 22(7):575-585
65. Mambula SS, Calderwood SK (2006) Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 177(11):7849-7857